CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


Pregnant women under investigation for Coronavirus or diagnosed with COVID-19Wiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (3)


Name (Synonyms) Correlation
drug897 Video-Based Wiki 1.00
drug639 Postpartum women under investigation for Coronavirus or diagnosed with COVID-19 Wiki 1.00
drug827 Telerehabilitation-Based Wiki 1.00

Correlated MeSH Terms (1)


Name (Synonyms) Correlation
D018352 Coronavirus Infections NIH 0.06

Correlated HPO Terms (0)


Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials


1 PRIORITY (Pregnancy Coronavirus Outcomes Registry)

PRIORITY (Pregnancy CoRonavIrus Outcomes RegIsTrY) is a prospective cohort study of pregnant and recently pregnant women who are: either patients under investigation for COVID-19 or a confirmed case of COVID-19. Data from PRIORITY will be used to evaluate the impact of COVID-19 on the clinical course and pregnancy outcomes of pregnant women and women within 6 weeks of pregnancy.

NCT04323839 Pregnancy Coronavirus COVID-19 Other: Pregnant women under investigation for Coronavirus or diagnosed with COVID-19 Other: Postpartum women under investigation for Coronavirus or diagnosed with COVID-19
MeSH:Coronavirus Infections

Primary Outcomes

Description: presenting symptoms and testing

Measure: Clinical presentation

Time: Baseline to 12 months

Description: Clinical outcomes with resolution of illness

Measure: Disease prognosis outcomes

Time: Baseline to 12 months

Description: Pregnancy outcomes among women infected with COVID-19

Measure: Pregnancy outcomes

Time: Baseline to 12 months

Description: Obstetric outcomes among women infected with COVID-19

Measure: Obstetric outcomes

Time: Baseline to 12 months

Description: Neonatal outcomes among infants born to women with COVID-19

Measure: Neonatal outcomes

Time: Baseline to 12 months

Description: Transmission of COVID-19 from mother to infant

Measure: Modes of transmission of COVID-19

Time: Baseline to 12 months


No related HPO nodes (Using clinical trials)